Compare DexCom, Inc. (DXCM) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? DexCom, Inc. trades at $77.31 (market cap $28.06B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.86. The key difference: DexCom, Inc. is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| DXCM | XDTE | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $89.53 | $44.76 |
52-Week Low | $54.84 | $36.00 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
XDTE (Roundhill S&P 500 0DTE Covered Call Strategy ETF) trades at $38.90, down 0.54% with a bullish technical signal from moving averages. The ETF employs a daily options strategy generating high dividend yields, with recent distributions ranging from $0.09 to $0.26 per share. Technical indicators show neutral oscillators with RSI at moderate levels, while support and resistance cluster around $39.
XDTE offers exceptional income generation through its 0DTE covered call strategy but faces significant NAV erosion risks despite S&P 500 highs. The ETF's high yield strategy appeals to income investors but requires careful monitoring of market volatility and payout sustainability. Recent analysis highlights the trade-off between income generation and capital preservation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
